ADAPTIVE BIOTECHNOLOGIESLOGIES CORP
ADAPTIVE BIOTECHNOLOGIESLOGIES CORP
Acción · US00650F1093 · ADPT · A2PLR5 (XNAS)
Resumen Indicadores financieros
10,09 USD
4,34 % 0,42 USD
NASDAQ (XNAS) · Precios actuales y gráficos en MoneyPeak
06.06.2025 20:00

Cotizaciones actuales de ADAPTIVE BIOTECHNOLOGIESLOGIES CORP

BolsaTickerMonedaÚltima operaciónPrecioVariación diaria
XNAS: NASDAQ
NASDAQ
ADPT
USD
06.06.2025 20:00
10,09 USD
9,87 USD
+2,23 %

Rendimiento

Día Semana Mes 3 meses 6 meses 1 año 5 años
0,00 % 4,99 % 14,53 % 37,28 % 60,93 % 179,50 % -73,95 %

Perfil de la empresa para ADAPTIVE BIOTECHNOLOGIESLOGIES CORP Acción

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID for the confirmation of past COVID-19 infection. It also provides clonoSEQ, a clinical diagnostic product for the detection and monitoring of minimal residual disease in patients with multiple myeloma, B cell acute lymphoblastic leukemia, and chronic lymphocytic leukemia, as well as available as a CLIA-validated laboratory developed test for patients with other lymphoid cancers; and immunoSEQ T-MAP COVID for vaccine developers and researchers to measure the T-cell immune response to vaccines. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. It serves the life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.

Fondos invertidos

Los siguientes fondos han invertido en: ADAPTIVE BIOTECHNOLOGIESLOGIES CORP invertido:

Fondo
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. en millones
182,24
Porcentaje (%)
0,43 %

Datos de la empresa

Nombre ADAPTIVE BIOTECHNOLOGIESLOGIES CORP
Empresa Adaptive Biotechnologies Corporation
Símbolo ADPT
Sitio web https://www.adaptivebiotech.com
Mercado principal XNAS NASDAQ
WKN A2PLR5
ISIN US00650F1093
Tipo de valor Acción
Sector Healthcare
Industria Biotechnology
CEO Mr. Chad M. Robins M.B.A.
Capitalización de mercado 1 Mrd.
País Estados Unidos de América
Moneda USD
Empleados 0,6 T
Dirección 1165 Eastlake Avenue East, 98109 Seattle
Fecha de OPV 2019-06-27

Símbolos de cotización

Nombre Símbolo
Frankfurt 1HM.F
NASDAQ ADPT

Otras acciones

Los inversores que tienen ADAPTIVE BIOTECHNOLOGIESLOGIES CORP también tienen las siguientes acciones en su cartera:
ABBOTT LABORATORIES INC
ABBOTT LABORATORIES INC Acción
ACTIVISION BLIZZARD INC
ACTIVISION BLIZZARD INC Acción
BASF SE
BASF SE Acción
BAYER AG
BAYER AG Acción
BYD
BYD Acción
DT.IND.REIT-AG
DT.IND.REIT-AG Acción
ILLUMINA INC
ILLUMINA INC Acción
INDIVIOR PLC ADR/5
INDIVIOR PLC ADR/5 Certificado de depósito
INFINEON TECHNOLOGIESLOGIES AG
INFINEON TECHNOLOGIESLOGIES AG Acción
INTELLIA THERAPEUTICSCS INC
INTELLIA THERAPEUTICSCS INC Acción
ISHSV-MSCI ACWI DL A
ISHSV-MSCI ACWI DL A ETF
NVIDIA CORP
NVIDIA CORP Acción
SAGE GROUP 25/37 MTN
SAGE GROUP 25/37 MTN Bono
VERTEX PHARMACEUTICALS INC
VERTEX PHARMACEUTICALS INC Acción
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras. Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Aviso legal Protección de datos Blog Comunidad Comentarios Changelog
Im App Store herunterladen Bei Google Play herunterladen
Todos los derechos reservados © LCP GmbH 2025